FDA approvals, GLP-1 updates and new cancer research tools.
October 15, 2025

1. FDA approves drug for high-risk skin cancer Full story

2. 5 GLP-1 updates Full story

3. Why ASC leaders are rethinking robotics: Lessons from UCSD and Memorial Hermann here.

4. Sam's Club sells Ozempic, Wegovy Full story

5. Cancer AI Alliance debuts cancer research platform Full story

 

6. Complex wounds, simpler healing — How 1 surgeon is speeding recovery + boosting comfort here.

7. CDC projects moderate flu season: What to know Full story

8. 20 most-prescribed medications: GoodRx Full story

Becker's Learning Opportunities

9. Big AI results, minimal disruption — see how healthcare leaders are making it work here.

10. 14 mins saved per prior auth request — how 5 leaders are making it happen, here.

11. An unmet need in neuroscience care is costing patients & systems. How OHSU addressed it here.

12. Becker’s resources don’t stop here — explore more webinars and whitepapers.

 

Companies to Know
Thank you to our key sponsors


LeanTaaS | Abridge | Philips | Vituity | ECG Management Consultants | CorroHealth | symplr | AMN Healthcare | Ambience Healthcare | Intuitive  

 

 
 

 

Contact Us, Feedback, or Questions – Email ldyrda@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker's Hospital Review, A Becker's Healthcare Publication